Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Revolution Medicines (RVMDW) Interest & Investment Income (2019 - 2025)

Historic Interest & Investment Income for Revolution Medicines (RVMDW) over the last 7 years, with Q3 2025 value amounting to $22.1 million.

  • Revolution Medicines' Interest & Investment Income rose 819.17% to $22.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.6 million, marking a year-over-year increase of 707.98%. This contributed to the annual value of $86.9 million for FY2024, which is 8298.09% up from last year.
  • According to the latest figures from Q3 2025, Revolution Medicines' Interest & Investment Income is $22.1 million, which was up 819.17% from $22.4 million recorded in Q2 2025.
  • In the past 5 years, Revolution Medicines' Interest & Investment Income registered a high of $24.9 million during Q1 2025, and its lowest value of $223000.0 during Q3 2021.
  • For the 5-year period, Revolution Medicines' Interest & Investment Income averaged around $11.3 million, with its median value being $10.5 million (2023).
  • Its Interest & Investment Income has fluctuated over the past 5 years, first plummeted by 7436.74% in 2021, then soared by 223741.72% in 2023.
  • Over the past 5 years, Revolution Medicines' Interest & Investment Income (Quarter) stood at $237000.0 in 2021, then skyrocketed by 2042.19% to $5.1 million in 2022, then soared by 273.78% to $19.0 million in 2023, then increased by 11.85% to $21.2 million in 2024, then grew by 4.04% to $22.1 million in 2025.
  • Its Interest & Investment Income stands at $22.1 million for Q3 2025, versus $22.4 million for Q2 2025 and $24.9 million for Q1 2025.